Figure 6.
NK cell increased expression of CD137, but not PD1, in FL and DLBCL patients. Expression of CD137 (TNFRSF9) and the exhaustion marker PD1 on NK cells before the treatment (day 0 – cycle 1), before the first infusion of OBZ (day 8 – cycle 1), before the treatment of 2nd cycle (end cycle 1) and finally at the end of the last cycle (end cycle 6). Statistical significance was determined by paired t-test between “day 0 – cycle 1” and the following time points; p values * * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001.